Advisory Board

The PREMIER advisory board will lend us scientific support and external expertise for our purpose. They will give us advice and help us in all scientific issues during the project.

Six members who are experts in the fields of open science / open data and scientific research, as well as a scientific publisher, scientific sponsor and a member of the Volkswagenstiftung are part of the advisory board.

List of members of the PREMIER advisory board:

Foto: Mirko Krenzel für VolkswagenStiftung

Dr. Oliver Grewe Scientific Consultant Life Sciences

Mitglied im Förderteam "Personen und Strukturen" der VolkswagenStiftung. Verantwortlich für die Bereiche Natur- und Lebenswissenschaften des Freigeist Fellowship Programms. Betreute bislang Vorhaben im Bereich der Evolutionsbiologie, Biomedizin und der Tropenmedizin.

Werdegang: Studium der Biologie, Musikwissenschaft, Kommunikationswissenschaft und Philosophie in Münster und Bologna. Promotion in Neurowissenschaften und Postdoc am Institut für Musikphysiologie und Musikermedizin, Hannover. Seit 2008 Tätigkeiten als wissenschaftlicher Referent bei der Studienstiftung des deutschen Volkes und der Wissenschaftlichen Kommission Niedersachsen. Außerhalb seiner Tätigkeit bei der Stiftung arbeitet Herr Grewe seit 2015 als Business Coach für Akademiker.

+49 511 8381-252

Prof. Dr. Anton Bespalov CEO, Partnership for Assessment and Accreditation of Scientific Practice GmbH

Prof. Bespalov obtained his MD degree from Pavlov Medical University (St. Petersburg) and after completion of PhD studies in St. Petersburg and Utrecht held NIH-supported Fellowships at Medical College of Virginia (Richmond, VA) and Scripps Institute (La Jolla, CA). After habilitation (DMedSci) in 2000, Anton acted as a research director of Valdman Institute of Pharmacology. In 2004, Anton joined Abbott (later AbbVie) but maintained close connections to Pavlov Medical University where he is a professor at the Institute of Pharmacology and chaired the University’s Scientific Advisory Board. During his tenure at Abbott / AbbVie as head of pharmacology department, Anton and his teams have brought several compounds into preclinical and clinical development, supported licensing and due diligence decisions. Anton has established and managed research contracts and collaborations with 100+ biotech companies, CROs and academic labs around the world. Founded and leads several international initiatives on preclinical data quality.


Prof. Dr. Michael Gotthardt Professor for Experimental and Translational Cardiology

Dr. Gotthardt is Professor of Experimental & Translational Cardiology at Max-Delbruck-Center for Molecular Medicine and Charité Medical School, Berlin. He has a track record of national and international collaboration including research initiatives (DZHK – German center for cardiovascular research with 28 German institutions), program project grants (SFB-TR/19 “inflammatory cardiomyopathy”, DFG research group “Regulation and deregulation of muscle growth”, DFG Research group “Structure, function, and regulation of the myofibrillar Z-disc interactome”, BMBF E:Bio program CaRNAtion / coordinator Michael Gotthardt), twinning grants between basic scientists and clinicians (institutional and DFG funded), and graduate programs (TransCard Helmholtz Research School / coordinator Michael Gotthardt and the DFG funded MyoGrad program). He is currently collaborating with >50 researchers and provides research reagents and animal models to the community.


Dr. Katja Hartig Program Director Life Sciences

  • Studium der Biologie von 1994 bis 2000, Universität Bayreuth
  • Promotion von 2001 bis 2004 im Bereich Molekularbiologie/Genetik, Universität Bayreuth
  • Projektleitung eines DFG-Projekts und wissenschaftliche Mitarbeiterin von 2005 bis 2007, Universität Bayreuth
  • seit 2007 als Fachreferentin in der DFG-Geschäftsstelle (Deutsche Forschungsgemeinschaft, Bonn) tätig
  • seit 2010 Querschnittsverantwortung für Themenfelder „Umgang mit Forschungsdaten“, Infrastrukturen und Digitaler Wandel
  • zuständig für das Fach „Epidemiologie, Medizinische Biometrie, Medizinische Informatik“ sowie die Technologie- und Methodenplattform für vernetzte Medizinische Forschung (TMF)
  • für die DFG im Dialogforum der Medizininformatik-Initiative des BMBF
  • seit 2016 stellvertretende Gruppenleitung der Gruppe Medizin
  • seit 2017 Mitglied der DFG-Projektgruppe „Digitaler Wandel in der Wissenschaft“
+49 228 885-2359

Dr. Bernd Pulverer Chief Editor and Head of Scientific Publications

Following undergraduate studies in Cambridge, Bernd received his PhD in 1992 from the Ludwig Institute for Cancer Research, London, for uncovering posttranslational regulation of the transcription factors c-Jun and c-Myc by the JNK and MAP kinases. He carried out postdoctoral research at the Ontario Cancer Institute, Toronto, the Fred Hutchinson Cancer Research Center, Seattle and at the University of Innsbruck. Bernd was associate and then senior editor at Nature from 1999 until 2002 and subsequently chief editor of Nature Cell Biology. He has been the chief editor of The EMBO Journal and Head of Scientific Publications at EMBO since 2009.


Dr. Paul Schultze-Motel Coordinator - Helmholtz Open Science

Dr. Paul Schultze-Motel has been working for the Open Science Coordination Office of the Helmholtz Association at Helmholtz Centre Potsdam (GFZ German Research Centre for Geosciences) since 2010. His previous positions include stages in science administration at Max-Delbrück-Centrum für Molekulare Medizin and at Technische Universität Berlin as well as jobs in digital publishing with several educational publishers. He is a biologist and received his Ph.D. from Freie Universität Berlin.

+49 331 288-1653